Preferred Label : opicapone;
MeSH note : structure in first source;
CISMeF synonym : BIA 9-1067;
MeSH synonym : 2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine
1-oxide;
Is substance : O;
UNII : Y5929UIJ5N;
InChIKey : ASOADIZOVZTJSR-UHFFFAOYSA-N;
Origin ID : C549349;
UMLS CUI : C2933912;
ATC code(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH indexing information
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.ema.europa.eu/en/medicines/human/EPAR/ontilyv
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
opicapone
opicapone
opicapone
ongentys
drug approval
europe
parkinson disease
Catechol O-Methyltransferase Inhibitors
Catechol O-Methyltransferase Inhibitors
adult
aged
Product containing precisely opicapone 25 milligram/1 each conventional release oral
capsule (clinical drug)
Product containing precisely opicapone 50 milligram/1 each conventional release oral
capsule (clinical drug)
administration, oral
drug therapy, combination
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
---
https://www.has-sante.fr/portail/jcms/c_2904836/fr/ongentys
https://www.has-sante.fr/portail/jcms/c_2904836/fr/ongentys-opicapone-anti-parkinsoniens-dopaminergiques
2019
false
true
false
false
France
French
treatment outcome
anti-parkinson drugs
adult
parkinson disease
drug therapy, combination
Motor fluctuations
administration, oral
Catechol O-Methyltransferase Inhibitors
evaluation of the transparency committee
insurance, health, reimbursement
guidelines for drug use
antiparkinson agents
levodopa
DOPA Decarboxylase Inhibitors
Aromatic Amino Acid Decarboxylase Inhibitors
opicapone
oxadiazoles
---
https://www.ema.europa.eu/medicines/human/EPAR/Ongentys
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
opicapone
oxadiazoles
drug approval
europe
treatment outcome
anti-parkinson drugs
product surveillance, postmarketing
adult
parkinson disease
drug therapy, combination
Motor fluctuations
administration, oral
drug interactions
pregnancy
breast feeding
Catechol O-Methyltransferase Inhibitors
Catechol O-Methyltransferase Inhibitors
opicapone
oxadiazoles
---